Steven Cohen Ventyx Biosciences, Inc. Call Options Transaction History
Point72 Asset Management, L.P.
- $40.1 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VTYX
# of Institutions
129Shares Held
44.8MCall Options Held
35.2KPut Options Held
40.6K-
Black Rock Inc. New York, NY4.77MShares$5.77 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$4.25 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA3.1MShares$3.75 Million0.23% of portfolio
-
Sio Capital Management, LLC New York, NY2.58MShares$3.13 Million1.12% of portfolio
-
Vestal Point Capital, LP New York, NY2MShares$2.42 Million0.16% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $68.4M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...